| 000 | 01744 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516080042.0 | ||
| 264 | 0 | _c20120817 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.06107-11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPulido, David | |
| 245 | 0 | 0 |
_aAntimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMay 2012 |
||
| 300 |
_a2378-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAgglutination _xdrug effects |
| 650 | 0 | 4 |
_aBacterial Adhesion _xdrug effects |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCarbohydrate Conformation |
| 650 | 0 | 4 |
_aCell Wall _xchemistry |
| 650 | 0 | 4 |
_aEosinophil Cationic Protein _xchemistry |
| 650 | 0 | 4 |
_aEosinophils _xcytology |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipopolysaccharides _xchemistry |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMicrobial Viability _xdrug effects |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aOligopeptides _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aRecombinant Proteins _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aMoussaoui, Mohammed | |
| 700 | 1 | _aAndreu, David | |
| 700 | 1 | _aNogués, M Victòria | |
| 700 | 1 | _aTorrent, Marc | |
| 700 | 1 | _aBoix, Ester | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 56 _gno. 5 _gp. 2378-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.06107-11 _zAvailable from publisher's website |
| 999 |
_c21542030 _d21542030 |
||